His lab is focusing on refining the alanine-scanning assay to some critical residues which will properly distinguish in between fibrils from neurodegenerative tauopathies. He envisions working with this streamlined assay for postmortem neuropathological analysis, and possibly for blood screening of tauopathies.You’re also planning to want to safe